Semen Parameters are Unrelated to BMI But Vary With SSRI Use and Prior Urological Surgery



Male infertility affects approximately 6% of reproductive-aged men. It has been suggested that overweight men or men with obese body mass index (BMI) experience prolonged time to pregnancy, though the influence of male BMI on fertility remains understudied. Aims: We hypothesized that BMI is inversely correlated with fertility, manifested by reduced sperm concentration, motility, and morphology.


Males of age 18 to 50 with semen analyses and self-reported BMI were included (n = 530). Patient parameters analyzed included age, BMI, smoking, urological, and fertility history. Leutinizing hormone (LH), Follicle-stimulating hormone, testosterone, steroid hormone-binding globulin (SHBG) and free androgen index (FAI) levels (n = 55), and selective serotonin reuptake inhibitor (SSRI) use (n = 12) were also measured.


The men in this study had a mean BMI of 28.2 ± 4.9 kg/m2 (range = 15–60), which is considered overweight, and a mean semen concentration of 55.4 ± 46.8 million/mL, which is in normal range, according to WHO standard. No consistent relationship was observed between increasing BMI and sperm concentration, motility, or morphology, although the testosterone levels trended downward with increasing BMI; there was a suggestion for decreased sperm concentration in current smokers. Men treated with combination SSRI and other psychotropic agent therapy (n = 12) had significantly reduced sperm motility (P =.009). Not unexpectedly, prior urological surgery (n = 77) was associated with lower sperm concentration (P =.0001) and morphology (P =.0008). When in vitro fertilization−embryo transfer (IVF-ET) was used as a treatment modality (n = 121), male BMI was not a significant predictor of clinical pregnancy (P =.06).


In our study, we did not observe a significant association between male BMI and sperm concentration, motility or morphology, or clinical pregnancy following IVF-ET. Significantly, SSRI use may affect sperm parameters negatively.

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.


  1. 1.

    Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod. 2007;22 (2): 414–420.

  2. 2.

    Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12 (1): 13–21.

  3. 3.

    Nguyen RH, Wilcox AJ, Skjaerven R, Baird DD. Men’s body mass index and infertility. Hum Reprod. 2007;22 (9): 2488–2493.

  4. 4.

    Sallmen M, Sandler DP, Hoppin JA, Blair A, Baird DD. Reduced fertility among overweight and obese men. Epidemiology. 2006;17 (5): 520–523.

  5. 5.

    Baker H, Burger H, deKretser D, Hudson B Male Reproductive Dysfunction: Diagnosis and Management of Hypogonadism, Infertiliy and Impotence. Santen R Swerdloff R, ed. New York, NY: Dekker; 1986.

  6. 6.

    Matsumoto AM Reproductive Endocrinology, Surgery and Technology. Adashi E Rock J Rosenwaks Z, ed. New York, NY: Raven Press; 1995.

  7. 7.

    Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, Heimisdottir M, Olafsdottir K. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod. 2005;20 (1): 208–215.

  8. 8.

    Kort HI, Massey JB, Elsner CW, et al. Impact of body mass index values on sperm quantity and quality. J Androl. 2006;27 (3): 450–452.

  9. 9.

    Tanrikut C, Schlegel PN. Antidepressant-associated changes in semen parameters. Urology. 2007;69 (1): 185.e5–7.

  10. 10.

    Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30 (4): 911–917.

  11. 11.

    Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care. 2004;27 (4): 861–868.

  12. 12.

    WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interactions. Cambridge: Cambridge University Press; 1999.

  13. 13.

    Kruger TF, Swanson RJ, Hamilton M, et al. Abnormal sperm morphology and other semen parameters related to the outcome of the hamster oocyte human sperm penetration assay. Int J Androl. 1988;11 (2): 107–113.

  14. 14.

    Morley JE, Patrick P, Perry HM. Evaluation of assays available to measure free testosterone. Metabolism. 2002;51 (5): 554–559.

  15. 15.

    Jensen TK, Andersson AM, Jorgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril. 2004;82 (4): 863–870.

  16. 16.

    Aggerholm AS, Thulstrup AM, Toft G, Ramlau-Hansen CH, Bonde JP. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile?. Fertil Steril. 2008;90 (3): 619–626.

  17. 17.

    Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW. Male obesity and alteration in sperm parameters. Fertil Steril. 2008;90 (6): 2222–2225.

  18. 18.

    Stewart TM, Liu DY, Garrett C, Jorgensen N, Brown EH, Baker HW. Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output. Hum Reprod. 2009;24 (7): 1561–1568.

  19. 19.

    Strain GW, Zumoff B, Kream J, et al. Mild Hypogonadotropic hypogonadism in obese men. Metabolism. 1982;31 (9): 871–875.

  20. 20.

    Pauli EM, Legro RS, Demers LM, Kunselman AR, Dodson WC, Lee PA. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril. 2008;90 (2): 346–351.

  21. 21.

    Nicopoulou SC, Alexiou M, Michalakis K, et al. Body mass index vis-a-vis total sperm count in attendees of a single andrology clinic. Fertil Steril. 2009;92 (3): 1016–1017.

  22. 22.

    Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril. 2010;93 (7): 2222–2231.

  23. 23.

    Fejes I, Koloszar S, Szollosi J, Zavaczki Z, Pal A. Is semen quality affected by male body fat distribution?. Andrologia. 2005;37 (5): 155–159.

  24. 24.

    Koloszar S, Fejes I, Zavaczki Z, Daru J, Szollosi J, Pal A. Effect of body weight on sperm concentration in normozoospermic males. Arch Androl. 2005;51 (4): 299–304.

  25. 25.

    Ramlau-Hansen CH, Thulstrup AM, Nohr EA, Bonde JP, Sorensen TI, Olsen J. Subfecundity in overweight and obese couples. Hum Reprod. 2007;22 (6): 1634–1637.

  26. 26.

    Keltz J, Zapantis A, Jindal SK, Lieman HJ, Santoro N, Polotsky AJ. Overweight Men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet. 6/16/2010 (e-pub ahead of print). 2010.

  27. 27.

    Santoro N, Lasley B, McConnell D, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the Study of Women’s Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004;89 (6): 2622–2631.

  28. 28.

    Roberts RJ. Can self-reported data accurately describe the prevalence of overweight?. Public Health. 1995;109 (4): 275–284.

  29. 29.

    Friedman BE, Rogers JL, Shahine LK, Westphal LM, Lathi RB. Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome. Fertil Steril. 2009;92 (4): 1312–1314.

  30. 30.

    Klock SC, Sheinin S, Kazer R, Zhang X. A pilot study of the relationship between selective serotonin reuptake inhibitors and in vitro fertilization outcome. Fertil Steril. 2004;82 (4): 968–969.

  31. 31.

    Selective Serotonin Reuptake inhibitor-Induced Sexual Dysfunction. Thomson Reuters Micromedex 1.0; 2008.

  32. 32.

    Maier U, Koinig G. Andrological findings in young patients under long-term antidepressive therapy with clomipramine. Psychopharmacology (Berl). 1994;116 (3): 357–359.

  33. 33.

    Levin RM, Amsterdam JD, Winokur A, Wein AJ. Effects of psychotropic drugs on human sperm motility. Fertil Steril. 1981;36 (4): 503–506.

Download references

Author information

Correspondence to Rachna Relwani MD or Sangita Jindal PhD.

Additional information

Author Note

All research described in this manuscript was performed in Montefiore’s Institute for ReproductiveMedicine and Health, Hartsdale, New York, USA, and MAZE Laboratories, Purchase, New York.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Relwani, R., Berger, D., Santoro, N. et al. Semen Parameters are Unrelated to BMI But Vary With SSRI Use and Prior Urological Surgery. Reprod. Sci. 18, 391–397 (2011).

Download citation


  • BMI
  • sperm
  • semen
  • fertility
  • SSRI
  • male